PT - JOURNAL ARTICLE AU - Antoni Torres AU - Michael S. Niederman AU - Jean Chastre AU - Santiago Ewig AU - Patricia Fernandez-Vandellos AU - Hakan Hanberger AU - Marin Kollef AU - Gianluigi Li Bassi AU - Carlos M. Luna AU - Ignacio Martin-Loeches AU - J. Artur Paiva AU - Robert C. Read AU - David Rigau AU - Jean François Timsit AU - Tobias Welte AU - Richard Wunderink TI - International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia AID - 10.1183/13993003.00582-2017 DP - 2017 Sep 01 TA - European Respiratory Journal PG - 1700582 VI - 50 IP - 3 4099 - http://erj.ersjournals.com/content/50/3/1700582.short 4100 - http://erj.ersjournals.com/content/50/3/1700582.full SO - Eur Respir J2017 Sep 01; 50 AB - The most recent European guidelines and task force reports on hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) were published almost 10 years ago. Since then, further randomised clinical trials of HAP and VAP have been conducted and new information has become available. Studies of epidemiology, diagnosis, empiric treatment, response to treatment, new antibiotics or new forms of antibiotic administration and disease prevention have changed old paradigms. In addition, important differences between approaches in Europe and the USA have become apparent.The European Respiratory Society launched a project to develop new international guidelines for HAP and VAP. Other European societies, including the European Society of Intensive Care Medicine and the European Society of Clinical Microbiology and Infectious Diseases, were invited to participate and appointed their representatives. The Latin American Thoracic Association was also invited.A total of 15 experts and two methodologists made up the panel. Three experts from the USA were also invited (Michael S. Niederman, Marin Kollef and Richard Wunderink).Applying the GRADE (Grading of Recommendations, Assessment, Development and Evaluation) methodology, the panel selected seven PICO (population–intervention–comparison–outcome) questions that generated a series of recommendations for HAP/VAP diagnosis, treatment and prevention.ERS/ESICM/ESCMID/ALAT evidence-based recommendations for HAP/VAP diagnosis, treatment and prevention http://ow.ly/dGhv30dAVoa